Answers are grounded in this paper and cite their sources.
The ability to identify BRCA1/2 mutations was found to be successful in the clinical management of ovarian cancer. Given the implications for clinical care and for advances in cancer prevention, identifying racial difference in genetic or lifestyle factors, which may modify the cancer risk due to BRCA1/2 mutations, is a high priority for future research.
No takes yet. Share an insight, caveat, or question.
Shanmughapriya et al. (2013) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: